Proposed U.S. Animal-Test Ban Not A Game Changer For Big Firms – NGO
This article was originally published in The Rose Sheet
Executive Summary
Cruelty Free International is confident that the EU's ban on cosmetic animal testing has eliminated the bulk of the practice, so the impact of a proposed U.S. ban under the Humane Cosmetics Act would be "quite small." On the other hand, the European ban's scope may not be as far-reaching as previously understood, and the Personal Care Products Council recently acknowledged that companies continue to consider animal testing for novel ingredients when alternative methods are not available to assess their safety.
You may also be interested in...
Highest EU Court To Interpret Cosmetic Animal-Test Ban’s Scope
The European Federation for Cosmetic Ingredients awaits a ruling from the European Court of Justice – expected in about two years – as to whether the ban in the EU necessarily prohibits the marketing of cosmetic ingredients tested on animals to meet regulatory requirements in third countries. Animal-welfare groups claim EFfCI’s aim is to “severely weaken” the ban and “herald a return to the dark days of animals suffering.”
ECHA Clarifies Exceptions To Cosmetic Animal-Test Ban; NGOs Regroup
The European Coalition to End Animal Experiments protests that “in practice, the animal tests bans would have virtually no application,” following ECHA’s clarification of REACH-related exceptions to Europe’s prohibition on animal testing for cosmetic ingredients. According to ECHA, the ban does not apply to testing required under REACH for “environmental endpoints, exposure of workers and non-cosmetic uses of substances.”
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they build frameworks for assessing cosmetic safety without animal tests. ICCS president and CEO Erin Hill discusses current challenges and what lies ahead.